These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Brown PD, Freeman A, Foxman B. Clin Infect Dis; 2002 Apr 15; 34(8):1061-6. PubMed ID: 11914994 [Abstract] [Full Text] [Related]
7. Escherichia coli resistance in uncomplicated urinary tract infection: a model for determining when to change first-line empirical antibiotic choice. Perfetto EM, Gondek K. Manag Care Interface; 2002 Jun 15; 15(6):35-42. PubMed ID: 12087605 [Abstract] [Full Text] [Related]
10. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, Prins JM, Koeijers J, Verbon A, Stobberingh E, Geerlings SE. Arch Intern Med; 2011 Jul 25; 171(14):1270-8. PubMed ID: 21788542 [Abstract] [Full Text] [Related]
11. Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection. Nguyen HT, Hurwitz RS, Defoor WR, Minevich E, McAdam AJ, Mortensen JE, Novak-Weekley SM, Minnillo BJ, Elder JS. J Urol; 2010 Jul 25; 184(1):305-10. PubMed ID: 20488468 [Abstract] [Full Text] [Related]
12. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis. Le TP, Miller LG. Clin Infect Dis; 2001 Sep 01; 33(5):615-21. PubMed ID: 11486284 [Abstract] [Full Text] [Related]
13. Trimethoprim/sulfamethoxazole resistance in urinary tract infections. Guneysel O, Onur O, Erdede M, Denizbasi A. J Emerg Med; 2009 May 01; 36(4):338-41. PubMed ID: 18325714 [Abstract] [Full Text] [Related]
14. Urinary tract infection in women over the age of 65: is age alone a marker of complication? Grover ML, Bracamonte JD, Kanodia AK, Edwards FD, Weaver AL. J Am Board Fam Med; 2009 May 01; 22(3):266-71. PubMed ID: 19429732 [Abstract] [Full Text] [Related]
16. Addressing antibiotic resistance. Gupta K. Dis Mon; 2003 Feb 01; 49(2):99-110. PubMed ID: 12601340 [Abstract] [Full Text] [Related]
17. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin. Bailey RR, Peddie BA. N Z Med J; 1988 Apr 27; 101(844):216-7. PubMed ID: 3283613 [No Abstract] [Full Text] [Related]
18. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections. Can F, Azap OK, Seref C, Ispir P, Arslan H, Ergonul O. Clin Infect Dis; 2015 Feb 15; 60(4):523-7. PubMed ID: 25378460 [Abstract] [Full Text] [Related]
19. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Raz R, Chazan B, Kennes Y, Colodner R, Rottensterich E, Dan M, Lavi I, Stamm W, Israeli Urinary Tract Infection Group. Clin Infect Dis; 2002 May 01; 34(9):1165-9. PubMed ID: 11941541 [Abstract] [Full Text] [Related]
20. Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005). Rock W, Colodner R, Chazan B, Elias M, Raz R. Isr Med Assoc J; 2007 Nov 01; 9(11):803-5. PubMed ID: 18085038 [Abstract] [Full Text] [Related] Page: [Next] [New Search]